Theratechnologies RPE
What is the RPE of Theratechnologies?
The RPE of Theratechnologies, Inc. is $1.529M
What is the definition of RPE?
Revenue per employee (RPE) is revenue divided by the number of employees of an organization.
= net income / number of employees
RPE of companies in the Health Care sector on TSX compared to Theratechnologies
What does Theratechnologies do?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Companies with rpe similar to Theratechnologies
- Solaris Oilfield Infrastructure Inc has RPE of $1.527M
- Muthoot Capital Services has RPE of ₨1.527M
- G5 Entertainment AB (publ) has RPE of kr1.527M
- Spotify Technology S.A has RPE of €1.528M
- The Bank of East Asia has RPE of HKD$1.528M
- Avantor has RPE of $1.529M
- Theratechnologies has RPE of $1.529M
- Eniro AB (publ) has RPE of kr1.530M
- Teck Resources has RPE of CAD$1.530M
- G-Resources has RPE of $1.530M
- Alvopetro has RPE of $1.530M
- China e-Wallet Payment has RPE of HKD$1.531M
- Putian Communication has RPE of ¥1.531M